A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 1

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 1

By Primary Care Education Consortium FEATURING Louis Kuritzky

2,403 views

November 30, 2023

4 Comments

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis

49:21

Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key

17:21

Ilene Fennoy

Obesity and Diabetes in Children

23:35

Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch

15:06

Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21

University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson

08:21

Omnipod®

The Omnipod 5 Algorithm: How it Works - TCOYD

Feat. S. Edelman, J. Pettus

10:14

Omnipod®

Automated Insulin Delivery Systems: The Omnipod 5 - TCOYD

Feat. S. Edelman, J. Pettus

12:26

Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

12:19

Omnipod®

Optimizing Omnipod 5 Therapy: Case Studies - TCOYD

Feat. S. Edelman, J. Pettus

15:33

Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

17:44

Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

26:49

Diana Isaacs

Tirzepatide Updates

26:32

Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen

20:24

Diana Isaacs

Tirzepatide for Type 2 Diabetes

19:26

Krista Varady

ADA 2022 Flipping the Metabolic Switch: Intermittent Fasting as a We…

44:43

Jason Fung

Type 2 Diabetes Aetiology and Reversibility

06:31

Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

33:23

Keck School of Medicine of USC

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Feat. M. Goran

05:08

Susan Brian

Login

Login

Join VuMedi

A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 1

Related Content